EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 26 April 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 101 - 150 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)	611-341-5	55965-84-9	Acute Tox. 2; Acute Tox. 3; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A
ethyl methyl ether	611-089-6	540-67-0	Flam. Gas 1; Press. Gas
troclosene sodium, dihydrate	610-700-3	51580-86-0	Acute Tox. 4; Eye Irrit. 2; STOT SE 3
pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide	610-007-6	422556-08-9	Skin Sens. 1
tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione	608-879-8	335104-84-2	Repr. 2; STOT RE 2; Skin Sens. 1
polyhexamethylene biguanide hydrochloride; PHMB	608-723-9	32289-58-0	Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O')copper; bis(N-cyclohexyl-diazenium-dioxy)-copper; [Cu-HDO]	608-595-4	312600-89-8	Flam. Sol. 1; Acute Tox. 4; STOT RE 2; Eye Dam. 1
methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate	608-192-3	283159-90-0	Carc. 2
polyhexamethylene biguanide hydrochloride; PHMB	608-042-7	27083-27-8	Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
XMC; 3,5-xylyl methylcarbamate	607-955-8	2655-14-3	Acute Tox. 4
piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O, O-dipropyl phosphorodithioate	607-329-4	24151-93-7	Acute Tox. 4
fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamide	607-285-6	239110-15-7	Repr. 2
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s	606-640-2	2079-00-7	Acute Tox. 2
tert-butyl propionate	606-566-0	20487-40-5	Flam. Liq. 2
spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate	606-523-6	203313-25-1	Repr. 2; STOT SE 3; Eye Irrit. 2; Skin Sens. 1A
(+/-)-(R,R)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane	606-373-1	197706-50-6	Skin Sens. 1
proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one	606-168-7	189278-12-4	Carc. 2
pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl-3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether	605-845-4	179101-81-6	Skin Sens. 1
bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane	605-769-1	17606-31-4	Acute Tox. 4
silthiofam (ISO); N-allyl-4,5-dimethyl-2-(trimethylsilyl)thiophene-3-carboxamide	605-752-9	175217-20-6	STOT RE 2
pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate	605-747-1	175013-18-0	Acute Tox. 3; Skin Irrit. 2
indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate	605-683-4	173584-44-6	Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea	605-666-1	173159-57-4	Carc. 2
dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3- thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide	605-329-9	163515-14-8	Acute Tox. 4; Skin Sens. 1
flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide	605-127-0	158062-67-0	Acute Tox. 4
zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide	605-037-1	156052-68-5	Skin Sens. 1
emamectin benzoate (ISO); (4''R)-4''-deoxy-4''-(methylamino) avermectin B1 benzoate	605-015-1	155569-91-8	Acute Tox. 3; STOT SE 1; STOT RE 1; Eye Dam. 1
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one	604-715-4	149979-41-9	Carc. 2; Repr. 2
dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide	604-712-8	149961-52-4	Carc. 2; Repr. 2; Acute Tox. 4
spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate	604-636-5	148477-71-8	Carc. 1B; Repr. 2; STOT RE 2; Skin Sens. 1B
oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate	604-430-5	144651-06-9	STOT RE 2
reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]	604-398-2	144171-61-9	Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
(2E)-3-phenylprop-2-enal	604-377-8	14371-10-9	Skin Sens. 1A
kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate	604-351-6	143390-89-0	Carc. 2
cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate	604-318-6	142891-20-1	Carc. 2; Skin Sens. 1
tritosulfuron (ISO) (containing ≤0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)	604-291-0	142469-14-5	Skin Sens. 1
flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide	604-290-5	142459-58-3	Acute Tox. 4; STOT RE 2; Skin Sens. 1
trifloxystrobin (ISO); methyl (E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl}acetate	604-237-6	141517-21-7	Lact.; Skin Sens. 1
isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone	604-222-4	141112-29-0	Repr. 2
iprovalicarb (ISO); isopropyl [(2S)-3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamate	604-209-3	140923-17-7	Carc. 2
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]	604-167-6	139968-49-3	Repr. 2; Lact.; STOT RE 2
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one	604-105-8	139001-49-3	Carc. 2; Repr. 2; Skin Sens. 1
picolinafen (ISO); N-(4-fluorophenyl)-6-[3-(trifluoromethyl)phenoxy] pyridine-2-carboxamide; 4′-fluoro-6-[(α,α,α-trifluoro-m-tolyl) oxy]picolinanilide	604-030-0	137641-05-5	STOT RE 2
acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine	603-921-1	135410-20-7	Repr. 2; Acute Tox. 3
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; STOT SE 3; Eye Dam. 1
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate	603-792-1	134098-61-6	Acute Tox. 3; Acute Tox. 2; Skin Sens. 1B
azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate	603-524-3	131860-33-8	Acute Tox. 3
famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione	603-520-1	131807-57-3	STOT RE 2
disodium tetraborate decahydrate	603-411-9	1303-96-4	Repr. 1B

Showing 101 - 150 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 April 2024. Database contains 4691 unique substances/entries.

Footer Nav Items